MECASERMIN (Increlex®)
Clinical Indication
For the treatment of growth failure in line with the NHSE Clinical Commissioning Policy.
Date of classification
February 2025
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.